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Introduction
Outcomes after hepatic resection have significantly
improved over the last few decades with an improvement
in procedure-related mortality from >20% to <5% in most
of the experienced centres.1-4 A number of factors have
contributed to this improvement in surgical outcomes,
including but not limited to improvised patient selection,
innovations in surgical technique, novel devices for
bloodless surgery and parenchymal transaction,
preoperative portal vein embolisation for contralateral
lobe hypertrophy, advanced anaesthetic management,
and enhanced postoperative care.2,5,6 Despite
improvements in patient survival, hepatic resection is still
associated with significantly high morbidity rates.7-9
Recent studies from the United States10 have
demonstrated that a high hospital mortality rate of
around 10% is still being observed in low-volume
hospitals, whereas the hospital mortality rate in high-
volume centres is less than 5%.
Despite the establishment of hepatic resection as a
therapeutic modality in the Western as well as Far Eastern
regions of the world, the development of liver surgery has
been suboptimal in most of the developing world
including South Asia. Most of the hospitals in the
developing countries remain relatively low volume
centres for hepatic resection and there are only a limited
number of published reports from developing countries
on this subject.11-13 Therefore, we decided to review the
early outcomes of hepatic resection at our hospital, which
is a low volume centre in a developing country with no
transplant facilities. The current study was planned to
determine the spectrum of presentation, magnitude of
surgical resection and short-term outcomes, including
blood loss, morbidity and mortality in patients
undergoing hepatic resection.
Patients and Methods
This study was conducted at the Aga Khan University
Hospital (AKUH), Karachi, from January 2008 to December
2015, and comprised patients who underwent hepatic
resection. The AKUH is a tertiary care hospital with no
transplant facilities. Data was retrieved through
International Classification of Diseases (ICD)-9 coding
system. The patients underwent elective hepatic
resection for various benign, malignant and metastatic
diseases during the study period. Hepatic resections
performed for trauma were excluded. The variables
studied included demographics, indication for surgery,
type of hepatic resections, duration of surgery, estimated
blood loss, transfusion requirements, and any
concomitant procedure along with hepatic resection.
Postoperative variables included surgical complications,
including wound infections, bile leak, intra-abdominal
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collection, and bleeding; systemic complications like liver
decompensation, pulmonary infections, and 30-day as
well as 90-day mortality. Length of the hospital stay and
need for intensive care unit (ICU) stay were also reviewed.
All patients had a triphasic computed tomography (CT)
scan or magnetic resonance imaging (MRI) to evaluate the
pathology of liver and assess the resectability of tumour.
Assessment of functional reserves of liver was based on
Child-Pugh class, liver biochemistry and coagulation
profile. Preoperative image guided biopsy was done in few
patients with diagnostic uncertainty. Patients undergoing
hepatectomy received general anaesthesia with invasive
monitoring and selective epidural analgesia. All patients
underwent an open procedure with selective use of
diagnostic laparoscopy in some cases. Intra-operative
ultrasound was routinely performed to define the
relationship between the tumour and major intrahepatic
vessels, any tumour invasion of portal vein or hepatic
veins, and to detect any lesions in the contralateral lobe.
Parenchymal transection was performed using harmonic
scalpel, diathermy or cavitron ultrasonic surgical aspirator
(CUSA). Pringle manoeuvre was used only when significant
bleeding was encountered. Instead, more attention was
paid to lowering of the central venous pressure to below 5
cm of water (H2O) to reduce venous bleeding during
transaction. Meticulous attention was paid to the
preservation of function in the remnant liver by avoiding
prolonged rotation, hypoxic injury, or venous congestion
due to overloading of circulation. After transaction,
bleeding and any leakage site was carefully repaired with
fine sutures. A routine cholangiogram was performed in all
patients undergoing left hepatectomy as well as any
patient with suspected aberrant anatomy. Fibrin glue was
used to seal the raw liver surface at the end of the
procedure. Drains were not routinely used.
All patients with major hepatic resection were monitored
in the special care unit in the immediate postoperative
period. Pain control was provided by continuous epidural
analgesia or patient controlled intravenous analgesia.
First-line antibiotics were given for about 3 days in the
postoperative period. Oral feeding was started as soon as
the bowel sounds returned and the early mobilisation was
encouraged. Salt free albumin and diuretic agent were
selectively used in cirrhotic patients who developed
ascites postoperatively. Patients were discharged once
clinically stable and regularly followed up in outpatient
clinics.
Mean and standard deviations were used to describe
categorical data whereas frequencies and proportions to
describe quantitative data. Univariate analysis was done
to look at the factors associated with morbidity, mortality
and blood loss during surgery. Statistical significance was
defined as p<0.05. SPSS 19 was used for data analysis. 
Results
Of the 75 participants, 43(57.3%) were males and
32(42.7%) were females. The overall mean age was 52±14
years. Besides, 47(63%) patients had American Society of
Anaesthesiologist (ASA) score of II, but 40(53%) patients
had at least one or more associated comorbid conditions.
All the patients had a Child-Pugh score of 5 or 6, with
2(2.7%) patients with Hilar Cholangiocarcinoma having
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Table-1: Baseline Parameters of Study Population.
Demographics
Male/Female (n) 43/32
Age (years, mean + SD) 52 ± 14
Co-morbid Conditions
Hypertension (n, %) 31 (41%)
Diabetes Mellitus (n, %) 23 (31%)
Chronic Obstructive Pulmonary Disease (n, %) 05 (7%)
Basic Laboratory Parameters:
Haemoglobin (gm/dL, mean + SD) 11.9 ± 1.9
Platelet count (X10E9/L, mean + SD) 257 ± 131
Serum Bilirubin (mg/dL, mean + SD) 0.64 ± 0.6
Serum Albumin (g/dL, mean + SD) 3.5 ± 0.8
Prothrombin time (seconds, mean + SD) 10.67 ± 2.6
ASA Level I/II/III 6/47/22
Cirrhosis 30 (40%)
ASA: American Society of Anaesthesiology.
SD: Standard Deviation.
Table-2: Indications for Surgery and Pathology.
Primary Malignant Pathology (n, %) 46 (61.3%)
Hepatocellular Carcinoma 37 (49.3%)
Carcinoma of Gallbladder 6 (8%)
Hilar Cholangiocarcinoma 2 (2.7%)
Embryonal Sarcoma 1 (1.3%)
Metastatic Malignancy (n, %) 18 (24%)
Metastatic Colorectal Malignancy 10 (13.3%) 
Metastatic Neuroendocrine tumour 2 (2.7%)
Metastatic renal cell carcinoma 2 (2.7%)
Adenocarcinoma of stomach (en bloc resection) 1 (1.3%)
Metastatic adrenocortical carcinoma 1 (1.3%)
Metastatic endometrial carcinoma 1 (1.3%)
Metastatic Breast carcinoma 1 (1.3%)
Benign Diseases (n, %) 11 (14.6%)
Focal nodular hyperplasia 2 (2.7%)
Giant Hemangioma 2 (2.7%)
Xanthogranulomatouscholecystitis 2 (2.7%)
Cystadenoma 1 (1.3%)
Liver cell adenoma 1 (1.3%)
Primary Paraganglioma of Liver 1 (1.3%)
Hepatolithiasis 1 (1.3%)
Nonspecific inflammation 1 (1.3%)
high bilirubin level (Table-1). 
Moreover, 37(49.3%) underwent hepatic resection for
underlying hepatocellular carcinoma (HCC) and 30(81%)
of these patients were cirrhotic. All the patients were
tested for hepatitis serology and 21(28%) were positive for
hepatitis C while 7(9%) had chronic hepatitis B infection.
Also, 18(24%) patients underwent hepatic resection for
metastatic malignancy and the most common indication
was colorectal cancer. A small proportion of patients
underwent hepatic resection for symptomatic benign
conditions or when the underlying diagnosis was not
clear (Table-2). Major hepatectomy (>3 segments) was
performed in 30(40%) patients; of them16(53%)had
hepatocellular carcinoma with underlying cirrhosis
(Table-3). 
Furthermore, 63(84%) had a solitary lesion and the mean
size of the lesion was 5.8cm. The mean duration of surgery
was 300±138 minutes with a mean estimated blood loss
(EBL) of 665ml. In a subgroup analysis, estimated blood
loss was significantly higher in patients with cirrhosis
(p<0.007) and patients who underwent hepatic resection
for primary hepatic malignancies (p<0.009). Estimated
mean blood loss was higher in patients who underwent a
major hepatectomy but the difference was not
statistically significant; on the other hand, the number of
pack cells transfused was significantly higher in patients
with major hepatectomy (p=0.003). Only 3(4%) patients
required postoperative mechanical ventilation and were
shifted to the intensive care unit, while others were
routinely managed in the special care unit with
subsequent care in the surgical ward.
Postoperative complications were observed in a total of
30(40%) patients and they were graded according to the
Clavien-Dindo classification. Surgical complications were
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Table-3: Extent of Hepatic Resection.
Major Hepatic Resections (> 3 segments) 30 (40%)
Right formal hepatectomy 19 (25.3%)
Right hepatectomy with caudate lobectomy 2 (2.7%)
Right extended hepatectomy 1 (1.3%)
Left formal hepatectomy 4 (5.3%)
Left extended hepatectomy 2 (2.7%)
Central hepatectomy 2 (2.7%)
Minor Hepatic Resections (< 2 segments) 45 (60%)
Radical cholecystectomy and segment IVB and V resection 7 (9.3%)
Left lateral segmentectomy 5 (6.7%)
Segmentectomy / subsegmentectomy 32 (42.6%)
Caudate lobectomy 1 (1.3%)
Additional Procedures 15 (20%)
Left hepaticojejunostomy 2 (2.7%)
RFA / wedge resection of another lesion 4 (5.3%)
Synchronous right hemicolectomy 5 (6.6%)
Sigmoid colectomy 1 (1.3%)
En-bloc total gasterectomy 1 (1.3%)
Right adrenalectomy 1 (1.3%)
Incisional hernia Repair 1 (1.3%)
RFA: Radiofrequency ablation.
Table-4: Short term Outcomes of Hepatic Resection.
Perioperative Variables Overall Major Resection Minor Resection p-value
ASA class > 2 (n, %) 22 (29%) 9 (12%) 13 (17%) 1.000
Cirrhotic Liver (n, %) 30 (40%) 9 (12%) 21 (28%) 0.229
Number of lesions 0.341
 Single lesion 63 (84%) 27 36
More than one lesion 12 (16%) 03 09
Mean size of lesion (cm ± SD) 5.8±3.9 7.3±5.8 4.8±3.2 0.022
Operating time (minutes, mean ± SD) 300±138 346 269 0.017
Estimated blood loss (ml, mean ± SD) 665±580 680 655 0.856
No of packed red cell transfused (mean+SD) 2 ± 1.67 2 1 0.010
Need for ICU stay (n, %) 3 (4%) 2 1 0.602
Margin of Resection on Pathology 1.00
 R0 72 (96%) 29 43
 R1 02 (2.6%) 01 01
 R2 01 (1.3%) 00 01
Overall Morbidity (n,%) 30 (40%) 14 16 0.349
Clavien-Dindo classification (I/II/III/IV/V) 9/4/9/5/3 3/2/6/1/2 6/2/3/4/1 0.405
30-day Mortality 3 (4%) 2 1 0.560
90-day Mortality 5 (6.7%) 3 2 0.383
ASA: American Society of Anaesthesiology
SD: Standard Deviation
ICU: Intensive care unit.
noticed in 15(20%) of the patients including surgical site
infection in 12(16%), bile leak in 4(5.3%), intra-abdominal
collection in 4(5.3%) and postoperative haemorrhage in
1(1.3%) patient. Isolated systemic complications were
observed in 5(6.7%) patients, while another 6(8%) patients
had combined surgical and systemic complications.
Moreover, 3(4%) patients had isolated liver decompensation
with progressive worsening of liver function tests and 5(6.7%)
had ascites requiring diuretics. Besides, 7(9.3%) patients had
pulmonary complications including pneumonia or pleural
effusion, while 1(1.3%) had Takotsubo's cardiomyopathy. 
Moreover, 72(96%) patients underwent an R0 resection
based on pathology report, while 2(2.6%) had an R1
resection and both of them had underlying HCC. Overall,
3(4%) patients expired within 30days of hepatic resection
and all of them had underlying cirrhosis and developed
progressive liver decompensation in the postoperative
period that did not respond to all the supportive
treatment. Also, 2(2.6%) more patients died in 3 months
making the 90-day mortality at 5(6.7%). One patient with
primary hepatic embryonal sarcoma had an R2 resection
due to extent of the disease and developed postoperative
haemorrhage and liver failure resulting in mortality. The
second patient had metastatic adrenocortical tumour and
presented later with dehydration and acute renal failure
resulting in death (Table-4). 
A univariate analysis was done to identify the factors
associated with postoperative morbidity and 90-day
mortality. The presence of one or more co-morbid
condition had a statistically significant association with
postoperative morbidity (p=0.018). On the other hand,
age more than 50 years, gender, nature of tumour, extent
of surgical resection or blood loss had no significant
association with short-term postoperative outcomes.
Morbidity rate in patients with and without underlying
cirrhosis was 50% and 33%, respectively, but the
difference was not statistically significant (p=0.149).   
Mean length of stay in hospital was 9.5±3 days and the
mean follow-up duration was 8±11 months. Recurrence of
the disease was observed in 10(13.3%) patients at one
year of follow-up including 8(10.7%) patients with HCC
and 2 (2.7%) patients who underwent hepatic resection
for metastatic disease. For patients with HCC, recurrences
were managed by transarterial chemoembolisation in
3(4%) patients, radiofrequency ablation of tumours in
2(2.7%) patients and medical therapy in the remaining
patients. Multimodal therapy with chemotherapy and
radiotherapy was given to the patients for colonic and
adrenocortical carcinoma recurrence (Table-5). 
Discussion
Hepatic resection has progressed from a high-risk surgery
to an established therapeutic modality with indications
ranging from primary hepatobiliary malignancy to
metastatic diseases.8,14 Progressive improvement in
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Table-5: Univariate analysis of factors for morbidity and 90-day mortality.
Variables Morbidity p-valve 90-day Mortality p-value
Age < 60 19 0.922 2 0.278
>60 11 3
Gender Male 17 0.924 2 0.417
Female 13 3
Comorbids 21 0.018 2 0.536
No comorbids 9 3
ASA level < II 18 0.098 2 0.119
>II 12 3
Tumour Malignant 25 0.901 5 0.289
Benign 5 0
Pathology HCC 17 0.3 3 0.621
Other tumours 13 2
Major Hepatic resection 14 0.336 3 0.345
Minor hepatic resection 16 2
Duration of surgery < 300mins 11 0.391 2 0.901
< 300mins 19 3
EBL < 500ml 16 0.45 3 0.578
>500ml 14 2
ASA: American Society of Anaesthesiology
HCC: Hepatocellular carcinoma
EBL: Estimated blood loss.
mortality rates over the years has evolved this procedure
into a safe therapeutic option for carefully selected
patients.9 However, in the developing world with limited
resources and scarcity of technology for proper
preoperative workup and energy devices for bloodless
surgery, hepatic resection is not still performed routinely
in many centres since it is considered a difficult procedure
associated with major blood loss and serious
postoperative complications.11
Formal hepatic resections at our centre started in 2008 by
a single hepatobiliary surgeon. A number of limitations in
our work environment have resulted in slow development
of this specialty at our hospital over the years. Some of the
contributing factors include the lack of proper referral
system for the patients, the absence of facilities for
sophisticated preoperative workup in high-risk patients,
lack of modern instruments and infrastructure, and
affordability of such procedures since the patients need to
pay out of their pockets for medical treatment. Slow
growth of such a demanding procedure over the years
also results in a long learning curve for the associated
support staff. Another important limiting factor is the
absence of liver transplant facilities at our centre, which
restricts the extent of liver resection in relatively high-risk
cirrhotic patients. Despite such overwhelming
constraints, we have managed to perform hepatic
resections in our low volume centre with early outcomes
being comparable to the specialised centres. 
We had an overall morbidity rate of 40%; although this
figure seems relatively high, it is comparable with that of
large series published previously.9,15 The main causes of
morbidity in our study included wound infections (16%),
bile leak (5.3%), intra-abdominal collections (5.3%),
pulmonary complications (9.3%) and ascites (6.7%).These
morbidities prolonged the postoperative recovery period,
but were successfully managed conservatively. Our
patient population was characterised by high population
of patients with HCC (49.3%) and hence with cirrhosis
(40%). Hepatic resection in cirrhotic patients is more
challenging than resections in normal livers with
increased risk of bleeding, septic complications and liver
failure.16,17 Several authors have emphasised the
importance of strict selection in terms of liver function
reserves in ensuring favourable perioperative outcomes
in patients with chronic liver disease.18 Indocyaninegreen
(ICG) clearance19 and CT volumetry20 are commonly used
in the developed countries to assess functional liver
reserves; but our selection was based on Child-Pugh score
due to non-availability of such sophisticated facilities.
Our 30-day mortality rate was 4% and mortality at one
year was 13.3%, which is comparable to the Western as
well as Far Eastern figures of 5.8% and 8.4%,
respectively.6,10 Several studies have compared morbidity
and mortality rates among high volume and low volume
centres which suggests mortality rates are significantly
lower (1.5% - 6.2%) in high volume centres compared with
low volume centres (3.7% - 24.4%) due to greater
experience and high level of care provided.21,22 Despite
being a low volume centre our 30-day mortality rate is
comparable and so low volume centres in developing
world should be encouraged to do resections where
patients might not be able to reach or afford high volume
centres.
We tried to evaluate the factors associated with morbidity
and mortality in our study, but the only significant
association was the presence of associated comorbids in
patients undergoing liver resection. In a similar previous
study from South Asia, the presence of comorbid illness
was found to be significantly associated with post-
hepatectomy morbidity and an independent risk factor
for postoperative mortality.11 Presence of underlying
cirrhosis in our patients resulted in significantly higher
blood loss and overall higher morbidity rates, but the
difference was not statistically significant. Our univariate
analysis failed to demonstrate any significant association
of short-term outcomes with other preoperative variables
and this could be either due to overall small number of
patients or diversity of underlying pathology in this
cohort of patients.
Conclusion
Despite limited resources and low volume set-up, hepatic
resection can be performed in our set-up with reasonable
early postoperative outcomes. Morbidity, mortality,
estimated blood loss and average transfusion
requirement was comparatively higher in cirrhotic
patients which can be further minimised with better
patient selection, meticulous surgical technique and use
of novel energy devices. There is a need to increase
awareness among the patients about improving
outcomes as well as train and encourage surgeons from
developing countries to take up such demanding surgical
procedures.
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